feedzop-word-mark-logo
searchLogin
Feedzop
homeFor YouUnited StatesUnited States
You
bookmarksYour BookmarkshashtagYour Topics
Trending
Terms of UsePrivacy PolicyAboutJobsPartner With Us

© 2026 Advergame Technologies Pvt. Ltd. ("ATPL"). Gamezop ® & Quizzop ® are registered trademarks of ATPL.

Gamezop is a plug-and-play gaming platform that any app or website can integrate to bring casual gaming for its users. Gamezop also operates Quizzop, a quizzing platform, that digital products can add as a trivia section.

Over 5,000 products from more than 70 countries have integrated Gamezop and Quizzop. These include Amazon, Samsung Internet, Snap, Tata Play, AccuWeather, Paytm, Gulf News, and Branch.

Games and trivia increase user engagement significantly within all kinds of apps and websites, besides opening a new stream of advertising revenue. Gamezop and Quizzop take 30 minutes to integrate and can be used for free: both by the products integrating them and end users

Increase ad revenue and engagement on your app / website with games, quizzes, astrology, and cricket content. Visit: business.gamezop.com

Property Code: 5571

Home / Health / Substandard Drugs Found in Himachal Pradesh

Substandard Drugs Found in Himachal Pradesh

20 Dec, 2025

•

Summary

  • 205 drug samples nationwide failed quality checks in November.
  • 49 substandard medicines were manufactured in Himachal Pradesh.
  • Notices issued to companies, recalling of stock ordered.
Substandard Drugs Found in Himachal Pradesh

A rigorous quality assessment by the Central Drugs Standard Control Organisation (CDSCO) has identified 205 drug samples across India as "not of standard quality" (NSQ). During November, 49 of these substandard medicines were found to have been manufactured by units within Himachal Pradesh. These included critical medications for common ailments such as fever, heart conditions, and diabetes, raising significant public health concerns.

The failed drug samples originated from various districts in Himachal Pradesh, with Solan accounting for 28, Sirmaur for 18, and Una for one. In response to these findings, notices have been officially issued to the manufacturing companies. They have been mandated to initiate a recall of the substandard stock currently available in the market. Further actions will be taken against these companies as per established regulations.

Authorities are urging the public to exercise caution and consult the CDSCO website for a list of the failed medicines. The Himachal Health Minister has stated that companies with repeated quality failures will face blacklisting. This situation has prompted criticism from opposition parties, highlighting potential lapses in manufacturing and quality control mechanisms within the state.

trending

Winter Storm Enzo snowed south

trending

Kanye West India concert debut

trending

Xbox: Free streaming with ads

trending

Dormant Bitcoin whale moves $85M

trending

Detroit schools announce closings

trending

Cars losing spare tire

trending

Tesla restarts Dojo 3

trending

Covid investment scam resurfaces

trending

Warriors beat Heat, Butler injured

Disclaimer: This story has been auto-aggregated and auto-summarised by a computer program. This story has not been edited or created by the Feedzop team.
Medications for fever, heart attacks, diabetes, epilepsy, and muscle spasms manufactured in Himachal Pradesh were found to be of substandard quality.
Notices have been issued to the companies, and they have been ordered to recall the faulty stock from the market. Further regulatory actions will follow.
The public can visit the website of the Central Drugs Standard Control Organisation (CDSCO) to find the list of medicines that failed quality tests.

Read more news on

Healthside-arrow

You may also like

21 Laborers Dead: Contractor & Mason Arrested

14 Dec, 2025 • 221 reads

Himachal's chill deepens: Temps to drop 4°C

13 Dec, 2025 • 178 reads

article image

Punjab's Diabetes Crisis: 10% Incidence Rate Alarms Health Officials

6 Dec, 2025 • 210 reads

article image

Contaminated Cough Syrup Linked to Child Deaths

2 Dec, 2025 • 232 reads

article image

Varanasi Supplier Jaiswal Accused of $100M Cough Syrup Scam

17 Nov, 2025 • 292 reads

article image